Indian J Sex Transm Dis Indian J Sex Transm Dis
Official Publication of the Indian Association for the Study of Sexually Transmitted Diseases
Indian J Sex Transm Dis
The Journal | Search | Ahead Of Print | Current Issue | Archives | Instructions | Subscribe | Login    Users online: 660   Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
 
ORIGINAL ARTICLE
Ahead of Print

Clinical, immunological, and virological outcomes in HIV patients on raltegravir-based salvage therapy


 Apex Immunodeficiency Centre, Department of Medicine, Base Hospital, Delhi Cantt, New Delhi, India

Correspondence Address:
Sumit Arora,
Department of Medicine, Base Hospital Delhi Cantt, - 110 010, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijstd.IJSTD_23_18

Objectives: The objective of the study is to assess the clinical, immunological, and virological outcomes in treatment-experienced HIV patients on raltegravir (RAL)-based salvage therapy. Methods: This was a retrospective, observational study of patients with suspected second-line antiretroviral therapy failure who were followed up for at least 6 months, from January 2013 to January 2017, after switching to salvage regimen. A total of 20 patients who fulfilled the inclusion criteria and who had RAL-based salvage therapy were assessed for clinical, immunological and virological response. The data were picked up from the electronic database of the center and analyzed. Results: Age, sex, date of initial diagnosis, date, and type of first line and second line regimens were documented, CD4count, and plasma viral load at the time of initiation and after 3 and 6 months were recorded. Undetectable viral load was documented in all patients at 6 months. No noticeable adverse effects were noted. Conclusion: This study clearly shows that RAL containing regimens have a high degree of effectiveness in treatment-experienced patients and show effective and durable suppression of viral load with low adverse effect rates and reliable long-term safety.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Deshwal R
    -  Arora S
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5    
    PDF Downloaded0    

Recommend this journal